PA
VCYT icon

Pinnacle Associates’s Veracyte VCYT Stock Holding History

Pinnacle Associates’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.47M Buy
107,769
+55,159
+105% +$2.04M 0.04% 315
2025
Q4 		$2.21M Sell
52,610
-542
-1% -$21.8K 0.03% 384
2025
Q3 		$1.82M Sell
53,152
-1,184
-2% -$34K 0.02% 401
2025
Q2 		$1.47M Buy
54,336
+230
+0.4% +$6.66K 0.02% 435
2025
Q1 		$1.6M Buy
+54,106
New +$2.06M 0.02% 407

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Pinnacle Associates's VCYT Position: Q1 2026 in Review

Pinnacle Associates increased its Veracyte (VCYT) stake by 105% in Q1 2026, buying an estimated $2.04M and bringing the position to 107,769 shares worth $3.47M. The position accounts for 0.04% of the portfolio, ranked #315.

Pinnacle Associates first reported a position in VCYT in Q1 2025 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Pinnacle Associates held 107,769 shares of Veracyte worth $3.47M as of Q1 2026.
  • Pinnacle Associates bought 55,159 Veracyte shares in Q1 2026, an estimated $2.04M.
  • Veracyte made up 0.04% of Pinnacle Associates's portfolio in Q1 2026, its #315 holding.
  • Pinnacle Associates first reported a position in Veracyte in Q1 2025 and has held it in 5 quarters since.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.